Alternating hemiplegia of childhood (AHC) is a rare neurological disorder that causes repeated episodes of temporary paralysis affecting one or both sides of the body. It occurs in roughly 1 in every 1,000,000 births, with symptoms typically appearing before 18 months of age. The condition is lifelong, and between episodes, most children develop lasting neurological difficulties including movement problems and cognitive delays.
What Causes AHC
AHC is a genetic condition, inherited in an autosomal dominant pattern, though most cases arise from a new (spontaneous) mutation rather than being passed down from a parent. The gene involved is called ATP1A3, which provides instructions for building part of the sodium-potassium pump in nerve cells. This pump is essential for maintaining the electrical balance neurons need to send signals properly. When the pump doesn’t work correctly, nerve cells misfire or fail to communicate, leading to the episodes of paralysis and other neurological symptoms that define the condition.
When Symptoms Typically Appear
The median age of onset falls between 3 and 5 months, though episodes can begin anywhere from the newborn period up to about 4 years old. Early signs often include abnormal eye movements, brief stiffening of the limbs, and episodes where one side of the body goes limp. Because the onset is abrupt and dramatic, these early episodes are frequently mistaken for seizures or even strokes. In fact, AHC was originally thought to be a type of migraine when it was first described in 1971, and misdiagnosis can persist for years.
Diagnostic criteria require a combination of features: symptom onset before 18 months, repeated episodes of paralysis that alternate between sides of the body (or affect all four limbs), episodes of abnormal muscle stiffness, unusual eye movements or changes in autonomic functions like heart rate and breathing, symptom relief during sleep, and evidence of developmental delay or other neurological problems such as unsteady movement or involuntary muscle contractions.
What Episodes Look and Feel Like
The hallmark of AHC is hemiplegia, meaning paralysis of one side of the body. These episodes can shift from one side to the other, sometimes within the same event, and can also progress to involve all four limbs. Episodes range from a few minutes to several days, and their frequency varies widely from child to child.
Beyond paralysis, children with AHC experience other types of episodes. Dystonic attacks, where muscles contract involuntarily and hold abnormal positions, are common and can affect a single limb or an entire side of the body. Abnormal eye movements, including episodes where the eyes drift or jerk rhythmically, often appear early and may be among the first symptoms parents notice.
A defining feature of AHC is that paralysis and most other episode types stop during sleep. This is one of the most reliable diagnostic clues: about 94% of patients experience symptom relief when they fall asleep. However, symptoms can return shortly after waking. Because of this consistent pattern, early sleep induction (helping the child fall asleep at the start of an episode) is one of the most practical strategies families use to manage attacks.
Common Episode Triggers
Episodes are often set off by environmental and psychological stressors. Documented triggers include physical exertion, illness, fever, prolonged fasting, and emotional excitement or stress. Environmental factors like bright or changing lights, extreme heat or cold, loud noise, and crowds can also provoke attacks. Water exposure during bathing or swimming is a well-known trigger. Even certain foods and odors, including chocolate and food dyes, have been reported to set off symptoms. Families often learn their child’s specific triggers over time and build daily routines around avoiding them.
Neurological Problems Between Episodes
AHC is not just a condition of isolated attacks. Between episodes, most children develop persistent neurological challenges that tend to worsen over time. These include cognitive impairment ranging from mild learning difficulties to more significant intellectual disability, movement disorders such as dystonia (sustained abnormal postures) and choreoathetosis (involuntary writhing or jerking movements), and unsteady gait.
Epilepsy is a major concern. The incidence of seizures in people with ATP1A3-related conditions may be as high as 75%. Unlike the paralysis episodes, seizures do not resolve with sleep, and they require separate treatment. In rare and severe cases, prolonged seizures (status epilepticus) can become life-threatening and require intensive hospital care.
How AHC Is Diagnosed
There is no single test that confirms AHC. Diagnosis relies on recognizing the characteristic clinical pattern, particularly the alternating paralysis that resolves with sleep. Genetic testing for ATP1A3 mutations can confirm the diagnosis in most cases, but some children who meet the clinical criteria do not have an identifiable mutation.
A major challenge is that AHC mimics several more common conditions. The abrupt onset of paralysis looks like a stroke. Dystonic stiffening is easily confused with epileptic seizures. The episodic nature can suggest hemiplegic migraine. Brain imaging with MRI, along with vascular and metabolic studies, is typically performed to rule out structural brain abnormalities, blood vessel problems, and metabolic disorders. The combination of alternating sides, onset in infancy, and consistent relief with sleep is what ultimately points toward AHC rather than these other conditions.
Treatment and Management
There is no cure for AHC, and treatment focuses on reducing how often episodes occur, shortening their duration, and managing the neurological problems that develop between attacks. The most widely used medication is flunarizine, a calcium channel blocker that can reduce the frequency of hemiplegic attacks. Response rates range from about 30% to 78% of patients showing some improvement, though complete symptom control occurs in only about 0 to 10% of cases. When flunarizine is discontinued, some patients experience a significant worsening of episodes and even severe regression in motor function.
Day-to-day management is largely in the hands of families. Identifying and avoiding triggers is a cornerstone of care. When episodes do occur, helping the child fall asleep as quickly as possible is the most consistently effective intervention. Many families develop personalized emergency plans in collaboration with their child’s medical team, particularly for managing prolonged seizures that may require hospital intervention.
Long-Term Outlook
AHC is a lifelong condition. The paralysis episodes themselves tend to continue into adulthood, though their character may change over time. The more significant long-term concern for most families is the progressive cognitive and motor impairment that accumulates between episodes. The severity varies considerably depending on the specific genetic mutation involved, and some mutations are associated with more severe outcomes than others.
Research into ATP1A3-related diseases is active. A large-scale natural history study has been tracking the long-term course of the condition to build a clearer picture of how it progresses and to create a benchmark against which future treatments, including potential genetic therapies, can be measured. For now, the focus remains on symptom management, trigger avoidance, and supporting developmental progress through therapies tailored to each child’s needs.